<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"CVD":1,
"Prohibitin":1,
"mitochondria":2,
"other diseases":1,
"oxidative stress":1,
"post-transcriptional and post-translational regulation":1,
"Larynx":2,
"Magnetic resonance imaging":1,
"Neoplasm":1,
"Staging":2,
"Surface coil":1,
"Adjuvant radiotherapy":1,
"Breast cancer":34,
"Breast irradiation":1,
"Dosimetry":3,
"Organs at risk":1,
"Prone crawl position":1,
"Prone position":2,
"Regional nodal irradiation":1,
"VMAT":1,
"CTHRC1":1,
"Metastasis":11,
"Prognosis":28,
"miR-30c":1,
"BED":1,
"Biologically effective dose":1,
"Head and neck radiation":1,
"Hypothyroidism":9,
"Late toxicity":1,
"British Thyroid Association 2014 guidelines":1,
"Differentiated thyroid cancer":11,
"E2F1":1,
"HBXIP":1,
"PKM2":3,
"proliferation":10,
"adrenal cortex":1,
"molecular genetics":1,
"neoplasia":1,
"neuroendocrine tumors":2,
"thyroid":37,
"BRAF mutation":4,
"DNA methylation":1,
"Personalized therapy":1,
"Thyroid cancer":76,
"Neck approach":1,
"Sternotomy":1,
"Substernal goiter":1,
"Tertiary center":1,
"Thyroidectomy":13,
"Breast tumor":1,
"Giant cell tumor":1,
"Giant cell tumor of soft tissue in breast":1,
"Extrathyroidal extension":4,
"Lateral lymph node metastasis":1,
"Papillary thyroid microcarcinoma":8,
"Predictive factor":1,
"4K 3D video microscope":1,
"Pituicytoma":1,
"Preoperative embolization":1,
"Spindle cell oncocytoma":1,
"fine-needle aspiration cytology":2,
"histology":1,
"thyroid neoplasms":26,
"ultrasonography":17,
"Central neck dissection":2,
"Lymph node metastasis":8,
"Lymph node ratio":1,
"Papillary thyroid carcinoma":41,
"JAK/STAT signaling pathway":1,
"JAK1":1,
"epithelial-mesenchymal transition":3,
"invasion":7,
"microRNA-520a-3p":1,
"migration":9,
"TRAF6":2,
"inflammation":3,
"miR-146b-5p":1,
"microRNA":3,
"renal cell carcinoma (RCC)":1,
"Epidemiology":5,
"Second primary thyroid cancer":1,
"Surveillance":1,
"and End Results":1,
"head and neck cancer":6,
"radiation":2,
"radiation-related malignancies":1,
"second primary malignancies":1,
"IDH2":2,
"Oncomine":1,
"PIK3CA":1,
"breast":1,
"carcinoma":8,
"papillary":2,
"tall cell":2,
"antidiabetic drug":1,
"cancer":19,
"dipeptidyl peptidase-4 inhibitor":1,
"type 2 diabetes":1,
"CUSUM":1,
"Endoscopic thyroid surgery":1,
"Learning curve":2,
"chemotherapy":2,
"maxillary sinus cancer":1,
"survival outcomes":1,
"central nervous system (CNS) tumor":1,
"late effects":1,
"radiation therapy":1,
"sarcoma":1,
"Cervical chyle fistula":1,
"Cirugía":1,
"Fístula quilosa cervical":1,
"Medium-chain fatty acids":1,
"Octreotida":1,
"Octreotide":2,
"Surgery":10,
"Tiroidectomía":1,
"Ácidos grasos de cadena media":1,
"HOXD cluster antisense RNA 1":1,
"biomarker":7,
"long noncoding RNA":2,
"3D quantitative nuclear telomere analysis":1,
"cancer stem-like cells":1,
"quantitative fluorescence in situ hybridization":1,
"BRAF":2,
"Central lymph node metastases":1,
"cN0":1,
"mPTC":1,
"Artificial intelligence":2,
"Fine-needle aspiration":10,
"Thyroid nodule":28,
"Epstein-Barr virus":2,
"anoikis":1,
"tumor development":1,
"MEN2":3,
"Medullary thyroid carcinoma":15,
"Prophylactic":1,
"Stat3":3,
"hnRNP-A1":1,
"let-7a-5p":1,
"pyruvate kinase isoenzyme type M2":1,
"SLUG":1,
"SNAIL":1,
"TWIST":1,
"E-CAD":1,
"follicular thyroid tumour":1,
"anaplastic thyroid carcinoma":9,
"fine needle aspiration":9,
"mediastinal seminoma":1,
"GLP-1 receptor agonist":1,
"exenatide":1,
"pancreatic cancer":1,
"molecular testing":6,
"laparoscopic gastrectomy":1,
"liver retraction":1,
"needle forceps":1,
"silicone disc":1,
"Contralateral lesions":1,
"Encapsulated tumors":1,
"FVPTC":1,
"Multifocality":2,
"NIFTP":4,
"Pathology":4,
"CyclinD1":1,
"Hurthle cell tumors":1,
"Immunohistochemistry":13,
"Ki-67":1,
"P53":2,
"Bioinformatics analysis":2,
"Long non-coding RNA":2,
"MIR22HG":1,
"NGS":1,
"cytology slide":1,
"microRNA classifier":1,
"personalized medicine":3,
"thyroid cancer diagnostic test":1,
"differentiated thyroid carcinoma":6,
"quality of care":1,
"thryoidectomy":1,
"thyroid nodules":15,
"CT":3,
"diagnosis":9,
"differential":1,
"dual-energy":1,
"iodine/analysis":1,
"microRNA classification":1,
"mutation analysis":1,
"risk reclassification":1,
"Chest–breast approach":1,
"Clearance of lateral lymph nodes":1,
"Endoscopic thyroidectomy":1,
"Lateral neck dissection":2,
"endobronchial tumor":1,
"granular cell tumor":1,
"Completion thyroidectomy":1,
"Complications":1,
"Hemithyroidectomy":3,
"Hormone replacement":1,
"Isthmolobectomie":1,
"Supplémentation hormonale":1,
"Thyroïdectomie totale":1,
"Total thyroidectomy":6,
"Totalisation":1,
"messenger RNA":1,
"Follicular lesions":1,
"Medical errors":1,
"Minimally invasive follicular thyroid carcinoma":1,
"Tissue sampling":1,
"SNHG15":1,
"lncRNA":2,
"melatonergic system":1,
"molecular marker":1,
"mutational burden":1,
"neoantigen abundance":1,
"pan-cancer analyses":1,
"tumor microenvironment":2,
"Cardiotoxicity":1,
"Checkpoint inhibitor toxicity":1,
"Hepatotoxicity":1,
"Immunotherapy":5,
"Metastatic giant cell bone tumor":1,
"Thyroid toxicity":1,
"Endocrine surgical procedures":1,
"Hypocalcaemia":1,
"Thyroid diseases":2,
"DNA mutational analysis":1,
"High-throughput nucleotide sequencing":1,
"Translational research":1,
"African American":1,
"germline variants":1,
"radioiodine refractory":1,
"2015 American Thyroid Association management guideline":1,
"Thyroid Imaging Reporting and Data System":3,
"Ultrasound":19,
"Adrenal tumor":1,
"Cortisol":1,
"Cushing’s syndrome":1,
"Cyclic-AMP":1,
"GNAS":1,
"Protein kinase A":1,
"ARMS":1,
"BRAF V600E mutation":3,
"Droplet digital PCR":1,
"Survivin":1,
"Diagnostic marker":1,
"PTC":7,
"Plasma microRNA":1,
"qRT-PCR":1,
"Cancer papillaire de la thyroïde":1,
"Differential expression":1,
"Expression différentielle":1,
"MicroARNs":1,
"MicroRNAs":2,
"Encapsulated follicular variant":1,
"Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)":1,
"Oncocytic":3,
"RAS":1,
"Cancer stem cells":4,
"Gene expression":2,
"Tumorigenesis":1,
"Apoptosis":10,
"LncRNA ANRIL":1,
"Papillary thyroid cancer":23,
"Propofol":1,
"convolutional neural network (CNN)":1,
"deep learning":3,
"Cancer stem cell":1,
"Gallbladder carcinoma":1,
"Lnc-DILC":1,
"β-Catenin":1,
"2-Deoxy-2-[18F]fluoro-D-glucose ([18F]FDG)":1,
"Glucose-6-phosphatase (G6Pase)":1,
"Positron emission tomography (PET)":1,
"Endoscopic transsphenoidal surgery":1,
"Hyponatremia":1,
"Pituitary adenoma":3,
"IgG4-related disease":1,
"Parathyroid adenoma":2,
"Parathyroid adenoma with prominent lymphocytic infiltrate":1,
"Parathyroid neoplasms":1,
"Angiogenesis":4,
"Cardio-oncology":1,
"Hypertension":2,
"Renal cell carcinoma":4,
"TCGA":1,
"network-regularized high dimensional cox regression":1,
"pathway databases":1,
"Fatty liver":1,
"HCC":2,
"NASH":1,
"Physiopathology":1,
"SP1":1,
"c-Myb":1,
"miR-1258":1,
"oral squamous cell carcinoma":1,
"false negative rate":1,
"Discharge":1,
"follow-up":2,
"recurrence":9,
"thyroid carcinoma":20,
"Acromegaly":6,
"Somatostatin analog treatment":1,
"Thyroid nodule volume":1,
"DNA mismatch repair":1,
"Lynch syndrome":1,
"follicular thyroid cancer":3,
"microsatellite instability":1,
"FMO1":1,
"RFS":1,
"classical papillary thyroid cancer":1,
"Anaplastic thyroid cancer":5,
"PD-1":2,
"PD-L1":1,
"BRAF V600E":3,
"Warburg effect":1,
"metabolic reprogramming":1,
"mitochondrial biogenesis":1,
"indeterminate":1,
"malignancy":8,
"pediatric":1,
"treatment":2,
"Microwave":1,
"Papillary carcinoma":7,
"Thermal ablation":1,
"multifocal":1,
"digital pathology":1,
"noninvasive follicular thyroid neoplasm with papillary-like nuclear features":1,
"nuclear scoring system":1,
"observer variation":1,
"tumors of uncertain malignant potential":1,
"ThyroSeq":2,
"benign call rate":1,
"indeterminate FNA":1,
"next generation sequencing":1,
"BRAFV600E":1,
"Artificial intelligence (AI)":2,
"Post-mortem computed tomography (CT)":1,
"Thyroid cartilage":1,
"Lenvatinib":4,
"Sorafenib":4,
"Thyroid cancer treatment":1,
"Treatment duration":1,
"Cancer progression":1,
"Moonlighting functions":1,
"Non-canonical localization":1,
"Nuclear translocation":2,
"Pyruvate kinase M2":1,
"BRCA1":1,
"correlation":1,
"ethnicity":1,
"meta-analysis":7,
"polymorphisms":3,
"Modena retractor":1,
"robotic":1,
"transaxillary":1,
"ATM":1,
"autophagy":4,
"lipophagy":1,
"mitophagy":1,
"pexophagy":1,
"selective autophagy":1,
"Hürthle cell":1,
"loss of heterozygosity":1,
"mtDNA":1,
"AIP":1,
"FIPA":1,
"lanreotide":1,
"pasireotide":1,
"resistant":1,
"somatostatin analog":1,
"Endoscopic thyroidectomy using vestibular approach":1,
"scar free thyroidectomy":1,
"transoral endoscopic thyroidectomy":2,
"Helical CT":1,
"Imaging, diagnostic":1,
"Neck":3,
"Parathyroid cancer":1,
"F-choline":1,
"PET/CT":6,
"elderly":2,
"high-risk patients":1,
"cardiovascular morbidity":1,
"cerebrovascular morbidity":1,
"hyperlipidemia":1,
"navitoclax":1,
"proto-oncogene proteins B-raf":1,
"vemurafenib":2,
"Blood supply protection":1,
"Level VI dissection":1,
"Superior parathyroid":1,
"Key gene":1,
"Papillary thyroid carcinom":1,
"Signaling pathway":2,
"Survival analysis":1,
"18F-Choline":1,
"18F-FDG":2,
"18F-FDOPA":1,
"Gallium-68":1,
"Primary hyperparathyroidism":1,
"Somatostatin":1,
"The Cancer Genome Atlas":1,
"microRNA-122":1,
"overall survival rate":1,
"Computed Tomography (CT)":1,
"Magnetic resonance imaging (MRI)":1,
"Ethanol ablation":1,
"Guidelines":1,
"Minimally invasive therapy":1,
"Thyroid neoplasm":4,
"FNA":2,
"miR-137":1,
"miR-181b":1,
"miR-214":1,
"miR-222":1,
"adjuvant therapy":1,
"consensus":1,
"radioiodine-refractory thyroid cancer":1,
"remnant ablation":1,
"ultra-low-dose CT":1,
"Carcinoma de células renales":1,
"Neoplasia metastásica":1,
"Neoplasm metástasis":1,
"Tiroides":1,
"DANCR":1,
"large intervening non-coding RNA":1,
"Epidemiology and prevention":1,
"Italy":1,
"incidence":3,
"mortality":3,
"time trend":1,
"Negative conversion":1,
"Radioactive iodine ablation":2,
"Thyroglobulin antibody":2,
"Thyroid peroxidase antibody":1,
"Area under the curve":1,
"Machine learning":6,
"Biopsy, needle":1,
"Mutation":4,
"acute myeloid leukemia":1,
"DALY":1,
"Ecuador":1,
"Latin America":1,
"YYL":1,
"Papillary thyroid cancer ∙ LncRNA ∙ proliferation ∙ biomarker ∙ MAPK":1,
"Diagnostic accuracy":2,
"Microcalcifications":1,
"Sri Lanka":1,
"Thyroid malignancy":3,
"Ultrasound characteristics":1,
"dedifferentiated":1,
"endocrine system":1,
"thyroid disease":4,
"Calcium":1,
"Hypocalcemia":1,
"Hypoparathyroidism":2,
"Echogenic foci":1,
"Thyroid TIRADS":1,
"cancer screenig":1,
"health behavior":1,
"Cancer survivorship":1,
"Neurocognitive function":1,
"Systematic review":2,
"HPV":1,
"aspiration cytopathology":1,
"bone and soft tissue cytology":1,
"endocrine glands":1,
"head and neck cytology":1,
"immunochemistry":1,
"immunocytochemistry":2,
"molecular diagnostics":3,
"neuroendocrine and endocrine lesions":1,
"non-gynecologic cytopathology":1,
"thyroid cytology":3,
"Algorithm":1,
"Genomic":1,
"Hürthle":1,
"Personalized healthcare":1,
"RNA-seq":3,
"Benign thyroid nodule":2,
"fine needle aspiration cytology":2,
"Lutetium":1,
"Peptide receptor radionuclide therapy":1,
"Receptors, somatostatin":1,
"Thyroid cancer, medullary":2,
"Carcinoma, papillary":2,
"CYFRA 21 1":1,
"biomarkers":4,
"lymph nodes":1,
"apparent diffusion coefficient":1,
"diffusion-weighted imaging":1,
"chest-breast approach":1,
"endoscopy":1,
"lateral lymph nodes":1,
"lymph node dissection":2,
"clinical pathology":1,
"9/11 disaster":1,
"World Trade Center":1,
"surveillance bias":1,
"Follicular neoplasm":2,
"TROP-2":1,
"Incidental papillary thyroid microcarcinoma":1,
"Benign breast lesion":1,
"Efficiency":1,
"Microwave ablation":1,
"Safety":1,
"circulating tumor DNA":1,
"liquid biopsy":2,
"target region sequencing":1,
"alternative splicing events":1,
"precision medicine":1,
"prognostic signature":1,
"splicing factors":1,
"Carcinoma, Medullary":2,
"HPV-related oropharyngeal cancer":1,
"Squamous cell carcinoma":6,
"TNM staging":1,
"Distant metastasis":3,
"Renal tumor":1,
"Hypothyroïdie":1,
"Nivolumab":3,
"Thyroiditis":7,
"Thyrotoxicose":1,
"Thyrotoxicosis":5,
"Thyroïdite":1,
"ASD":1,
"Autism":1,
"Comorbidity":1,
"Multimorbidity":1,
"Transcriptome":1,
"daily walking duration":1,
"physical activity":1,
"prevention":3,
"Aspirin":1,
"Metformin":1,
"endocrine cancer":3,
"plastic and reconstructive surgery":1,
"radiology":2,
"skin cancer":1,
"medullary thyroid cancer":3,
"small cell carcinoma":2,
"telomerase reverse transcriptase":1,
"v-raf murine sarcoma viral oncogene homologue B1":1,
"ATP2A3":1,
"Ca2+ release":1,
"ER stress":1,
"Salinomycin":1,
"FOXD2-AS1":1,
"TERT":2,
"18FDG-PET":1,
"Hashimoto's disease":2,
"autoimmune thyroid disease":1,
"chromogranin A":3,
"metanephrines":1,
"paraganglioma":1,
"pheochromocytoma":2,
"ATC":1,
"FTC":1,
"HSPA9":1,
"MTC":2,
"Mito-CP":1,
"mortalin":1,
"ALK-positive adenosquamous carcinoma":1,
"ALK-positive lung cancer":1,
"Alectinib":1,
"Interrater reliability":1,
"agreement":1,
"TIRADS":1,
"Clear cell carcinoma":1,
"Metastatic renal cell cancer":1,
"Sunitinib":2,
"TSH":2,
"Thyroid-stimulating hormone":1,
"Functioning metastases":1,
"papillary carcinoma thyroid":1,
"Hypercalcemia":2,
"hyperparathyroidism":3,
"minimally invasive surgical procedures":1,
"reoperation":1,
"single-photon emission computed tomography/computed tomography":1,
"low-risk differentiated thyroid carcinoma":1,
"stimulated thyroglobulin":1,
"pathergy":1,
"pyoderma gangrenosum":1,
"multiple endocrine neoplasia type 2A":1,
"rearranged during transfection proto-oncogene":1,
"Follicular proliferation":1,
"Lobectomy":1,
"TIR3B":1,
"Fine needle aspiration citology":1,
"Follicular":1,
"Goiter":2,
"Kidney transplantation":1,
"Skip metastasis":2,
"Da Vinci Xi":1,
"Remote access surgery":1,
"Robotic-assisted":1,
"Trans-axillary approach":1,
"American Thyroid Association guidelines task force":1,
"Lobohystmectomy":1,
"Thyroid surgery":1,
"Elderly patients":1,
"Prophylactic central neck dissection":1,
"Hypocalcemia,Thyroidectomy,Thyroid disease,parathyroid":1,
"Ossification, Heterotopic":1,
"Thyroid Gland":6,
"EMT":5,
"EYA1":1,
"FNDC3B":1,
"hepatocellular carcinoma":5,
"tumor growth":3,
"ectopic thymus":1,
"elastography":1,
"metastatic lymph node":1,
"AKT":2,
"NECTIN4":1,
"colorectal cancer":5,
"extranodal extension":1,
"neutrophil to lymphocyte ratio":1,
"nomograms":2,
"oral cancer":1,
"perineural spread":1,
"YAP":1,
"cancer metabolism":1,
"glucose transporter":1,
"quality of life":2,
"NUPR1":1,
"PDGFA":1,
"Thyroid hormone receptor":1,
"Dual energy CT":1,
"TNM":1,
"cervical lymph nodes":2,
"lymphadenopathy":1,
"spectral CT":1,
"thyroid cartilage invasion":1,
"bone methastases":1,
"long bones":1,
"surgical treatment":1,
"Calcitonin":7,
"Nodular disease":1,
"Bone":1,
"Metastases":1,
"Antineoplastic agents":1,
"Treatment outcome":1,
"Tyrosine kinase inhibitors":3,
"Carcinoembryonic antigen":3,
"Cisplatin":2,
"Iodine Contrast Media":1,
"Photoelectric":1,
"Radiotherapy":4,
"dysphagia":1,
"laryngology":1,
"miscellaneous":1,
"neurological disorders":1,
"otolaryngology":1,
"rehabilitation":1,
"swallow/dysphagia":1,
"vocal cord dysfunction":1,
"vocal fold paralysis":1,
"Thyroid cancer cells":1,
"aquaporin-1":1,
"miR-223":1,
"Aging":1,
"CD44":1,
"Splice variant":1,
"management of thyroid nodules":1,
"Computed Tomography":1,
"Hypervascular Mass":1,
"Neoplasm Metastasis":1,
"Positron Emission Tomography Computed Tomography":1,
"Renal Cell":1,
"PCNA":1,
"tumor stage":1,
"lymphovascular invasion":1,
"thyroid micropapillary carcinoma":1,
"thyroid papillary carcinoma":3,
"Cancer intervention":2,
"Oncology":1,
"Stroke":2,
"Therapeutic indications":1,
"TNF-α":1,
"interleukin-6":1,
"interleukin-8":1,
"Autophagy/mitophagy":1,
"Expression profiles":1,
"Mitochondrial genomes":1,
"Nuclear genomes":1,
"Oncocytic phenotype":1,
"Extraosseous Ewing sarcoma":1,
"Nerve sheath tumor":1,
"Primitive neuroectodermal tumor":1,
"Sciatic nerve":1,
"Active surveillance":3,
"Prospective cohort":1,
"Head/neck":1,
"dual-energy CT":1,
"image quality":1,
"radiation exposure":1,
"gene mutation":1,
"cribriform-morular variant of papillary thyroid carcinoma":1,
"inherited thyroid cancer":1,
"molecular genetic analysis":1,
"poorly differentiated papillary thyroid carcinoma":1,
"β-catenin gene mutation":1,
"Cell growth":1,
"PI3K/AKT":1,
"SPC24":1,
"CDKN2A":1,
"CDKN2B":1,
"HRAS":2,
"Palbociclib":1,
"Tipifarnib":1,
"medical overuse":1,
"Breast cancers":1,
"Chemotherapy resistance":1,
"Tamoxifen":1,
"Vitamin D receptor":1,
"effective half-life":1,
"radioiodine therapy":1,
"recombinant human thyroid-stimulating hormone":1,
"thyroid uptake":1,
"exercise":1,
"neoplasms":4,
"obesity":3,
"potential impact fraction":1,
"risk factors":3,
"131I therapy":1,
"documentation":1,
"security checkpoint":1,
"FT-UMP":1,
"clear cell change":1,
"endocrine pathology":1,
"follicular thyroid tumor":2,
"HOXA-AS2":1,
"HOXA3":1,
"Wnt/β-catenin signaling pathway":1,
"miR-15a-5p":1,
"head and neck lesion":1,
"intraoperative diagnosis":1,
"liquid-based cytology of rinsed tissue fragments":1,
"Differentially expressed gene":1,
"Fusion genes":1,
"Radioactive iodine therapy":1,
"Recombinant human thyrotropin":1,
"Renal function":1,
"Thyroid hormone withdrawal":1,
"Diagnostic value":1,
"head and neck":1,
"lymph node":3,
"salivary gland":1,
"incidental thyroid cancer":1,
"non-incidental thyroid cancer":1,
"combination therapy":2,
"orthotopic mouse model":1,
"programmed cell death-1":1,
"Core Needle Biopsy":3,
"metastasis pattern":1,
"operation extent":1,
"tomography":1,
"Nature of thyroid nodule":1,
"Radiofrequency ablation":3,
"Therapeutic success":1,
"Volume reduction":1,
"cytoplasmic elongation":1,
"palisaded pattern":1,
"soap bubble appearance":1,
"tall cell variant":2,
"tombstone appearance":1,
"Bilateral axillo-breast approach":1,
"Parathyroid":1,
"Robotic thyroidectomy":2,
"SCASI":1,
"Subcapsular saline injection":1,
"Zenker's diverticulum":1,
"Choline":1,
"Incidental":3,
"Positron emission tomography":1,
"Thyroid incidentaloma":3,
"multiple endocrine neoplasias":1,
"prophylactic surgical procedures":1,
"clomiphene":1,
"infertility":2,
"population cohort":1,
"endocrine gland neoplasms":1,
"follicular variant":2,
"histologic variants":1,
"PET-CT Scan":1,
"Guideline":1,
"Mouth Neoplasms":1,
"Republic of Korea":1,
"PTH":1,
"Parathyroid adenomas":2,
"Rapid washout":1,
"CD56":2,
"Follicular-variant":1,
"Galectin-3":2,
"HBME-1":1,
"TNM classification":1,
"outcome assessment":1,
"tumour staging":1,
"Esophageal injury":1,
"Esophageal stenting":1,
"Tracheomalacia":1,
"Transsternal approach":1,
"Vertebral metastasis":1,
"Neuroendocrine cells":1,
"Thyroglossal duct":1,
"Thyroglossal duct cyst":1,
"18F-FDG PET/CT":1,
"EU-TIRADS":1,
"high-density lipoprotein cholesterol":1,
"metabolic syndrome":1,
"thyroid volume":1,
"waist circumference":1,
"(131)I":1,
"Cáncer diferenciado de tiroides":1,
"Dynamic risk stratification":1,
"Estratificación dinámica de riesgo":1,
"Estratificación inicial de riesgo":1,
"Initial risk stratification":1,
"Radioiodine treatment":1,
"Tratamiento con radioyodo":1,
"remote-access thyroidectomy":2,
"transoral thyroidectomy":3,
"Fusion imaging":1,
"Hybrid imaging":1,
"Single-photon emission computed tomography/ultrasound":1,
"JAK":1,
"NF-κB":2,
"(68)Ga-Dotatate":1,
"Ectopic pituitary adenoma":1,
"Hyperthyroidism":3,
"Afirma":1,
"GSC":1,
"atypia":1,
"indeterminate cytology":2,
"radiology—treatment":1,
"Epithelial ovarian cancer":1,
"Follicle-stimulating hormone":1,
"Glycolysis":2,
"Pyruvate kinase isozyme type M2":1,
"TTN-AS1":1,
"ZNRF2":1,
"ceRNA":1,
"miR-153-3p":1,
"Central lymph node dissection":1,
"Thymectomy":1,
"Chinese women":1,
"LC-MS/MS":1,
"Thyroid autoantibody":1,
"Urinary bisphenol A":1,
"Cytokines":2,
"Sapylin":1,
"Wound Healing":1,
"Cervical cancer":2,
"POLR2E":1,
"rs3787016":1,
"Network medicine":1,
"Prediction of response":1,
"Breg":1,
"Thyroid tumor":2,
"Iodine Radioisotopes":1,
"Neck Dissection":4,
"Argonaute proteins":1,
"Hallmark of cancer":1,
"Mononucleotide A-T repeats":1,
"Universal target":1,
"cis-Regulatory elements":1,
"assisted reproduction":1,
"female infertility":1,
"fertility treatment":1,
"calcification":1,
"tumor volume doubling time":1,
"Noninvasive follicular thyroid tumor with papillary-like nuclear features (NIFTP)":1,
"18F-Choline PET-CT":1,
"PET-CT":1,
"mismatch repair":1,
"exosome":2,
"miRNA":4,
"Cancer incidence":2,
"Epidemiological study":1,
"Görtschitztal valley":1,
"Hexachlorobenzene":2,
"Mesothelioma":1,
"Structure-activity relationships":1,
"Ovarian cancer":2,
"Survival":5,
"TSH suppression therapy":1,
"dabrafenib":1,
"radioactive iodine":3,
"redifferentiation":1,
"trametinib":1,
"C cell hyperplasia":2,
"disease model":1,
"knock-in":1,
"reporter line":1,
"ret mutant":1,
"adenomatous polyposis coli":1,
"colorectal neoplasms":1,
"genotype":1,
"germline pathogenic variants":1,
"phenotype":1,
"Neutrophil–lymphocyte ratio":1,
"platelet–lymphocyte ratio":1,
"Central lymph node metastasis":1,
"Urinary iodine":2,
"follicular adenoma":1,
"noninvasive follicular thyroid neoplasm":1,
"3R":1,
"endocrine cancers":1,
"precilinal trials":1,
"AJCC eighth edition":1,
"Neck mass":1,
"Complication":1,
"Conservative thyroidectomy":1,
"53BP1":1,
"DNA damage response":1,
"genomic instability":1,
"immunofluorescence":2,
"thyroid follicular tumors":1,
"MMP20":1,
"SIBLING-MMP interaction":1,
"dentin sialophosphoprotein":1,
"in situ proximity ligation assay":1,
"tissue microarrays":1,
"Curcumin":1,
"Piperin":1,
"TPC-1 cells":1,
"Vitamin E":1,
"Hippo signalling pathway":1,
"TNRC6C-AS1":1,
"serine/threonine kinase 4":1,
"5-fluorouracil":1,
"HMGA2":1,
"chemoresistance":1,
"lncRNA prostate cancer-associated transcript 6":1,
"miR-204":1,
"tumor size":2,
"8505C cells":1,
"sodium orthovanadate":1,
"X-chromosome inactivation pattern":1,
"clonal analysis":1,
"human androgen receptor gene":1,
"Autonomous thyroid function":1,
"Iodine exposure":1,
"Nodular goiter":1,
"Intermediate risk":1,
"Papillary cancer":1,
"Treatment results":1,
"Immune-checkpoint inhibitor":1,
"ketoacidosis":1,
"non-small cell lung cancer":2,
"type 1 diabetes mellitus":1,
"Notch signaling":1,
"T helper 17 cells":1,
"gastric cancer":3,
"regulatory T cells":1,
"charcoal tattoo":1,
"differentiated thyroid cancer recurrence":1,
"surgical complications":1,
"Esophageal NEC":1,
"Gastroenteropancreatic NET":1,
"Large cell esophageal NEN":1,
"MANEC":1,
"Bcl-2":1,
"Bcl-XL":1,
"miR-1915-3p":1,
"Lysosome":1,
"Protein translation":1,
"Starvation":1,
"TFEB":1,
"mTORC1":1,
"Fine-needle biopsy":1,
"Molecular pathology":2,
"Overtreatment":2,
"Intraparotid node":1,
"Mucoepidermoid carcinoma":1,
"Parotid cancer":2,
"131I measurement":1,
"Chernobyl":1,
"External contamination":1,
"Internal contamination":1,
"HER2 status":1,
"Nomogram":2,
"Prediction and validation":1,
"JNK":1,
"ROS":2,
"SIRT1":2,
"miR-124":1,
"PROX1":2,
"cytoskeleton":2,
"follicular thyroid carcinoma":3,
"9/11":1,
"screening":1,
"Transoral robotic thyroidectomy":2,
"25(oh)D3":1,
"Correlation analysis":1,
"Deficiency of vitamin D":1,
"Insulin-like growth factor-1":1,
"TERT promoter mutation":2,
"Targeted next generation sequencing":1,
"bone marrow":1,
"complete blood count":1,
"radioiodine":2,
"Minor":1,
"Pathology, clinical":1,
"Thyroid neosplams":1,
"Cold atmospheric plasma":1,
"calreticulin":1,
"colon cancer":2,
"high-mobility group box 1 protein":1,
"MMP-2":1,
"PFOA":1,
"Mature cystic teratoma":1,
"carcinoid":1,
"Poorly differentiated thyroid carcinoma":1,
"Tyrosine kinase inhibitor":1,
"NIFTP incidence":1,
"ROM":1,
"Thyroid Bethesda":1,
"Thyroid cytopathology":3,
"Aerobic glycolysis":1,
"Proanthocyanidin B2":1,
"Advanced thyroid carcinoma":1,
"Tyrosine kinase inhibitor (TKI)":1,
"MET/EMT":1,
"adiponectin":2,
"high-density lipoproteins":1,
"leptin":1,
"low-density lipoproteins":1,
"signaling pathways":1,
"RUNX2":1,
"epigenetic":1,
"epithelial mesenchymal transition":1,
"histone":1,
"lung cancer":3,
"Acinic cell carcinoma":1,
"High-grade transformation":1,
"Intraparotid node metastasis":1,
"COX-2":1,
"Macrophages":1,
"Oncogene-induced senescence":1,
"PGE2":1,
"Thyrocytes":1,
"function analysis":1,
"therapeutic target":2,
"kinase inhibitors":1,
"microvessel density":1,
"tumors":1,
"COPB2":1,
"carcinogenic biomarkers":1,
"drug data mining":1,
"genetic and epigenetic drug targets":1,
"genetic and epigenetic network":1,
"next-generation sequencing (NGS) data":1,
"positive CD133 cancer stem cells":1,
"BRAF inhibition":1,
"sodium":1,
"iodide symporter":1,
"Risk assessment":2,
"aggressiveness":2,
"signal transduction":1,
"spheroids":1,
"target":1,
"three-dimensional growth":1,
"laryngeal cancer":1,
"laryngeal neoplasm":1,
"laryngo-esophageal disfunction":1,
"multidisciplinary team":1,
"Artificial neural network":2,
"Variant pathway":1,
"Adipocytes":1,
"Exosomes":1,
"Tumour progression":1,
"JNK-MIEF1 pathway":1,
"MDA-T32 cells":1,
"Mitochondrial fission":1,
"C-index":1,
"cancer staging":1,
"dendrogram":1,
"drug discovery screening":1,
"estrogen receptor":1,
"nuclear receptors":1,
"primary cells":1,
"Hashimoto’s thyroiditis":3,
"Calcitonin negative":1,
"Procalcitonin":1,
"Endocrine surgery":1,
"Hyperparparathyroidism":1,
"MEN 1":1,
"Parathyroid Carcinoma":1,
"Parathyroidectomy":1,
"Fine needle aspiration biopsy":1,
"Thyroid ultrasound":2,
"Cytokeratin-20":1,
"Merkel cell carcinoma":1,
"Thyroid Transcription Factor-1":1,
"primary cutaneous neuroendocrine carcinoma":1,
"Lymphocyte-to-monocyte ratio":1,
"three-dimensional laparoscopy":1,
"imaging examination":1,
"ESE-1":1,
"gene therapy":1,
"microbubbles":1,
"theranostics":1,
"ultrasound contrast agent":1,
"controlled ovarian stimulation":1,
"fertility agents":1,
"infertility treatment":1,
"ovulation induction":1,
"CT, computed tomography":1,
"IJV, internal jugular vein":1,
"Jugular vein":1,
"MRI, magnetic resonance imaging":1,
"PET/CT, positron emission tomography/computed tomography":1,
"Plasmacytoma":1,
"Tumoral thrombus":1,
"Child":1,
"Elasticity imaging techniques":1,
"Thyroid nodule/diagnostic imaging":1,
"Cervical":1,
"Foreign-born":1,
"Immigrant":1,
"Liver":1,
"Stomach":1,
"US-born":1,
"Cystic changes":1,
"Exophthalmia":1,
"Lacrimal gland":1,
"Solitary fibrous tumour":1,
"limited calcitonin expression":1,
"parafollicular cell tumor":1,
"Bariatric surgery":1,
"Beta cell function":1,
"Glucagon-like peptide 1":1,
"Brain":1,
"morphology":1,
"Cellulitis":1,
"papillary cystic carcinoma":1,
"circDENND4C":1,
"miR-200b":1,
"miR-200c":1,
"Anoctamin":1,
"clinical outcomes":1,
"colon carcinoma":1,
"laparoscopic surgery":1,
"open surgery":1,
"cancer-associated adipocyte":1,
"miRNAs":1,
"Thyroid nodular disease":1,
"MZ-CRC-1":1,
"heparin-binding EGF-like growth factor":1,
"mechanism":2,
"medullary thyroid carcinomas":1,
"miR-376c-3p":1,
"Pituitary":2,
"5-Aminopyrazole-4-carboxamide":1,
"Metabolic stability":1,
"RET kinase":1,
"Specific inhibitor":1,
"Analogue":1,
"Calcitriol":1,
"Receptor":2,
"Vitamin D":1,
"GH":1,
"IGF1":1,
"Canine":1,
"Hypothalamic-pituitary-thyroid axis":1,
"Nonthyroidal illness":1,
"Tumor staging":1,
"Next-generation sequencing":5,
"SETTLE":1,
"efflux pumps":1,
"thyroid dysfunction":1,
"PNS antibodies":1,
"paraneoplastic optic neuropathy":1,
"paraneoplastic syndrome (PNS)":1,
"children":2,
"iodine supply":1,
"thyromegaly":1,
"Artificial pneumothorax":1,
"Carina":1,
"Mediastinal goiter":1,
"Two-lung ventilation":1,
"Lateral neck node":1,
"HER2":1,
"HER3":1,
"Phosphorylated HER3":1,
"Trastuzumab":1,
"breast cancer diagnosis":1,
"computed diffusion weighted imaging (cDWI)":1,
"diffusion weighted imaging (DWI)":1,
"voxelwise cDWI (vcDWI":1,
"Minimal extrathyroidal extension":1,
"Postoperative nonstimulated thyroglobulin":1,
"124I":1,
"PET imaging":1,
"orthotopic models":1,
"Benign thyroid disease":1,
"Prospective study":1,
"Local infiltration":1,
"Poorly differentiated component":1,
"Fluorescent in situ hybridization":1,
"Iodine avidity":1,
"Lymph node metastases":1,
"Prognostic factor":1,
"RET/PTC rearrangement":1,
"Reverse transcription polymerase chain reaction":1,
"clinical parameter":1,
"gut microbiota":1,
"metabolite":1,
"predictive model":1,
"BAP1":1,
"BAP1-tumor predisposition syndrome":1,
"bilateral uveal melanoma":1,
"in silico analysis":1,
"branchial cleft cyst":3,
"congenital":2,
"fourth branchial cleft cyst":1,
"pre-sternal region":1,
"unique location":1,
"16S rRNA gene sequencing":1,
"Clinical index":1,
"Gut microbiome":1,
"cancer susceptibility candidate 2 (CASC2)":1,
"long noncoding RNA (lncRNA)":3,
"papillary thyroid carcinoma (PTC)":1,
"SEER program":1,
"propensity score":2,
"hypoxia-inducible factor 1 alpha (HIF1A)-antisense RNA 2 (HIF1A-AS2)":1,
"HOX transcript antisense RNA (HOTAIR)":1,
"gastric cancer (GC)":1,
"promoter analysis":1,
"cytology":3,
"poorly differentiated carcinoma":1,
"ThinPrep":1,
"cytologic features":1,
"Capsular invasion":1,
"Follicular-patterned thyroid carcinoma":1,
"Gross examination":1,
"Vascular invasion":1,
"eosinophilia":1,
"molecular":1,
"mucoepidermoid":1,
"sclerosing":1,
"chyle leak":1,
"chylous fistula":1,
"postoperative complications":2,
"wound vac therapy":1,
"large nodules":1,
"IRAK1":1,
"miR146a":1,
"microRNA-539":1,
"secretory leukocyte protease inhibitor":1,
"transforming growth factor β1/Smads signaling pathway":1,
"Intrathyroidal ectopic thymus tissue":1,
"Atrophic glossitis":1,
"Gastric parietal cell antibody":1,
"Thyroid microsomal antibody":1,
"Iodothyronine deiodinase":1,
"Thyroid hormone metabolism":1,
"TGF-β2":1,
"miR-618":1,
"anaplastic":2,
"spindle cell":1,
"thyroid follicular carcinoma":1,
"bio-heat transfer":1,
"finite element analysis":1,
"thermography":1,
"thyroid gland tumors":1,
"Immune-checkpoint inhibitors":1,
"Bilaterality":2,
"Clonal origin":1,
"Early stage":1,
"Field cancerization":1,
"childhood cancer incidence":1,
"sex differences":1,
"Multikinase inhibitor therapy":1,
"Radioactive iodine refractory":1,
"ultrasound guided needle biopsy":1,
"Lateral neck":1,
"Multimodal ultrasound Imaging":1,
"Real-time elastography":1,
"Superb microvascular imaging":1,
"Afirma Gene Expression Classifier":1,
"CD36":1,
"Dexmedetomidine":1,
"Resveratrol":2,
"Radioiodine-refractory PTC":1,
"immune system":1,
"lymphocytes":1,
"monocytes":1,
"Fine needle aspiration (FNA)":1,
"Review":2,
"TBRSTC":1,
"Childhood":1,
"paediatric":1,
"Ageing population":1,
"Projections":1,
"Shanghai":1,
"Anterior pituitary":1,
"Hypopituitarism":1,
"Nonfunctioning pituitary adenoma":1,
"Pituitary surgery":1,
"Radioguided occult lesion localization":1,
"A meta-analysis":1,
"Excessive iodine intake":1,
"Lewis lung carcinoma":1,
"Tetrac":1,
"integrin αvβ3":1,
"thyroid hormone":1,
"thyroxine":1,
"Ruyiping":1,
"cell cycle":2,
"Calcitonin screening":1,
"Outcome":2,
"RET/PTC1":1,
"Drug resistance":1,
"Euthyrox":1,
"MAP4K3":1,
"miR-206":1,
"sodium/iodide symporter":1,
"AKT/MAPK":1,
"Radioresistance":1,
"TRIP4":1,
"Telomerase":2,
"Microcarcinoma":2,
"Non-incidental":1,
"CDK7":1,
"PPP1R15A":1,
"THZ1":1,
"super-enhancer":1,
"transcriptional addiction":1,
"cabozantinib resistance":1,
"nanocells":1,
"targeted intravenous delivery":1,
"tumor suppressors":1,
"random forest":1,
"death risk":1,
"hazard":1,
"recurrence risk":2,
"Cure models":1,
"Cure proportion":1,
"Population based cancer registry":1,
"Statistical cure":1,
"Time-to-cure":1,
"Benign thyroid nodules":1,
"Minimally invasive techniques":1,
"Thermal ablation therapy":1,
"Aryl hydrocarbon receptor":1,
"Endocrine disruptor":1,
"Mammary gland":1,
"Follicular variant of PTC":1,
"FTIR":1,
"Follicular thyroid adenoma":2,
"PCA-LDA":1,
"Raman spectroscopy":1,
"Evaluation of neck nodes":1,
"Head and neck ultrasound":1,
"Office-based ultrasound":1,
"FAPI":1,
"growth":1,
"high-mobility group box 1 (HMGB1)":1,
"triptolide":1,
"adverse outcome":1,
"pregnancy":2,
"adrenal tumour":1,
"circadian rhythm":1,
"clock genes":1,
"ovarian tumour":1,
"pituitary adenomas":1,
"testis tumour":1,
"RNA sequencing":1,
"immunogenomics":1,
"tumor immunology":1,
"age at diagnosis":1,
"genetic risk score":1,
"AKI stage":1,
"acute kidney injury":1,
"all-cause mortality":1,
"cancer treatment":1,
"nanoparticle albumin-bound paclitaxel":1,
"neoadjuvant chemotherapy":2,
"pathological complete response":1,
"GEF/GAP":1,
"MKP":1,
"RAS/ERK":1,
"scaffold":1,
"I/Cr ratio":1,
"Iodine nutrition":1,
"Urine iodine concentration":1,
"PET (Positron emission tomography)":1,
"PSMA (Prostate-specific membrane antigen)":1,
"CAFs":1,
"TCA cycle":1,
"anaplerosis":1,
"energy metabolism":1,
"heterogeneity":1,
"pyruvate carboxylase":1,
"reverse Warburg effect":1,
"TRAIL":1,
"siRNA":1,
"tumor":3,
"BRAFV600E mutation":2,
"CEA":1,
"Ki67":1,
"Arsenic trioxide":1,
"Epithelial to mesenchymal transition":1,
"Maternally expressed gene 3":1,
"Pyruvate kinase muscle isoform 2":1,
"Functional and oncological outcome":1,
"Retropharyngeal node":1,
"Cell proliferation and apoptosis":1,
"PI3K/Akt and GSK-3β/β-catenin cascades":1,
"Pseudolaric acid B":1,
"STAT3 and ERK pathways":1,
"Head and neck tumor":1,
"Lymph-node metastasis":1,
"Metastasis of unknown primary":1,
"neoplasm of the ureter":1,
"renal pelvic carcinoma":1,
"FOXD3-AS1":1,
"clinical validation":1,
"Chinese Han population":1,
"IL1R1":1,
"IL1R2":1,
"association study":1,
"21-Gene oncotype Dx":1,
"Adjuvant decision-making":1,
"Independent predictors":1,
"Peptide P11":1,
"Prognostic marker":1,
"TRIP6":1,
"miR-7":1,
"CXCR1":1,
"EGFR":1,
"E-cadherin":2,
"Regional nodal recurrence":1,
"Malignant glomus tumor":1,
"microscopy":1,
"Neuroendocrine":1,
"TTF-1":1,
"chromogranin":1,
"endometrial carcinoma":1,
"synaptophysin":1,
"Atypia of undetermined significance":1,
"Risk of malignancy":1,
"Sub-category":1,
"RP11-547D24 1":1,
"lncRNAs":1,
"Genetic screening":1,
"Multiple endocrine neoplasia":1,
"RET":1,
"AXIN2":1,
"polymorphism":2,
"Clinicopathological variables":1,
"ESCC":1,
"TRIP13":1,
"Cancer tissues":1,
"LabSat":1,
"Microfluidic technology":1,
"RAI therapy":1,
"clinical response":1,
"BI-847325":1,
"Cyclin D1":1,
"MALAT1":1,
"Mcl1":1,
"miR-363-3p":1,
"Thyroid hormones":2,
"Thyroid stimulating hormone":1,
"Thyroid cancer, papillary":2,
"Thyrotropin":1,
"Biopsy, large-core needle":1,
"Chinese herbal medicine":1,
"Xiaoaiping":1,
"alopecia,":1,
"chemotherapy-induced side effects":1,
"HSDL2":1,
"NFATc2":1,
"PPP3CA":1,
"protein kinase B":1,
"PD-1 inhibitor":1,
"PDL-1 inhibitor":1,
"Pembrolizumab":1,
"Small cell carcinoma of ovary":1,
"poorly differentiated thyroid cancer":1,
"salidroside":1,
"Degenerating nodules":1,
"Imaging":1,
"Interstitial pneumonia":1,
"Mediastinal mass":1,
"Thorax":1,
"CDX2":1,
"ISL1":1,
"Neuroendocrine tumor":1,
"PAX8":1,
"SATB2":1,
"TTF1":1,
"next-generation sequencing (NGS)":1,
"thyroid fine-needle aspiration":1,
"hyalinizing trabecular tumor":1,
"central node dissection":1,
"multiple endocrine neoplasia type 2":2,
"prophylactic thyroidectomy":1,
"Nodules":1,
"Immune escape":1,
"Interleukin-17A":1,
"MHC class I molecule":1,
"PD-1/PD-L1":1,
"microRNA-423-3p":1,
"Papillary carcinoma of thyroid":1,
"Sistrunk’s procedure":1,
"Thyroglossal cyst":1,
"Disease-free survival":1,
"Overall survival":1,
"Stromal tumor-infiltrating lymphocytes":1,
"Triple negative breast cancer":1,
"laryngeal squamous cell carcinoma":1,
"lncRNA HOTAIR":1,
"lncRNA PTCSC3":2,
"AGEs":1,
"aminoguanidine":1,
"glyoxalase 1":1,
"methylglyoxal":1,
"Endometrial cancer":1,
"Endometrioid carcinoma":1,
"Medroxyprogesterone acetate therapy":1,
"Mesonephric-like adenocarcinoma":1,
"Müllerian duct":1,
"Chemokines":1,
"IGF-IEc":1,
"insulin-like growth factor-I (IGF-I)":1,
"MPPED2":1,
"MPPED2-AS1":1,
"methylation":1,
"tumor suppressor":1,
"IGFBP7":1,
"Carcinome thyroïdien":1,
"Gen-Expressions-Classifier":1,
"Next-Generation-Sequencing":1,
"Schilddrüsenkarzinom":1,
"Thy":1,
"classificateur d’expression génique":1,
"gene expression classifier":1,
"molekulare Testung":1,
"séquençage de nouvelle génération":1,
"tests moléculaires":1,
"Environmental health":1,
"Health impact assessment":1,
"Randomized trial":1,
"Risk communication":1,
"Statistical indicators":1,
"Time needed to harm":1,
"clinicopathological characteristics":1,
"miRNA-146b-5p":1,
"Anti-PD-1 antibody":1,
"Dysfunction":1,
"organic nanoparticle":1,
"orthotopic liver cancer":1,
"photothermal therapy":1,
"second near-infrared":1,
"semiconducting polymer":1,
"Nondiagnostic cytology":1,
"EGFR-sensitizing mutations":1,
"Stage IV lung adenocarcinoma":1,
"TTF-1 expression":1,
"Periodontal ligament stem cells":1,
"Periodontitis":1,
"Toll-like receptor 4":1,
"Follicular variant papillary thyroid cancer":1,
"Biopsy":1,
"Cytodiagnosis":2,
"Fine-Needle":1,
"BRD4":1,
"TERT promoter":1,
"combined therapies":1,
"epigenetic drugs":1,
"telomeres":1,
"Iodine refractory differentiated thyroid cancer":1,
"MEK inhibitor":1,
"Phase II":1,
"Radioiodoine therapy":1,
"Selumetinib":1,
"Local feature":1,
"Multi-direction":1,
"Non-quantitative":1,
"Rotation invariant":1,
"SVM classifier":1,
"Texture descriptor":1,
"three-dimensional power Doppler ultrasound":1,
"vascular indices":1,
"VOCAL":1,
"Statin":1,
"vascular endothelial growth factor":1,
"dyslipidemia":1,
"adipose tissue":1,
"liquid-based preparation":1,
"immunoPET":1,
"medullary thyroid carcinoma (MTC)":1,
"pretargeted imaging":1,
"radioimmunoconjugate":1,
"theranostic (therapeutic and diagnostic)":1,
"OCA2":1,
"Pathologic complete response":1,
"Rs4778137":1,
"Single nucleotide polymorphisms":1,
"CINCA Syndrome":1,
"NLRP3 MUTATION":1,
"cytopathology":1,
"diagnostic medicine":1,
"organ system pathology":1,
"pathology competencies":1,
"thyroid tumor staging":1,
"Activating anaplastic lymphoma kinase":1,
"Advanced non-small cell lung cancer":1,
"Adverse drug reaction":1,
"Anlotinib":1,
"Anti-angiogenesis":1,
"Epidermal growth factor receptor":2,
"National Medical Products Administration":1,
"cerebral hemorrhage":1,
"cumulative incidence":1,
"hazard ratio":1,
"infarction":1,
"osteoporosis":1,
"thyroid-stimulating hormone suppression treatment":1,
"Risk factor":1,
"Human papillomavirus":1,
"Nasopharyngeal carcinoma":1,
"Toll-like receptor":1,
"PTEN":1,
"VEGF":1,
"HTLV-1":1,
"clinicopathological factors":1,
"genetic abnormalities":1,
"genetic markers":1,
"oncogenic mutations":1,
"genetics":1,
"whole-genome studies":1,
"locoregional failure":1,
"non-anaplastic":1,
"Health disparities":1,
"Hispanic":1,
"Overdiagnosis":1,
"Puerto Rico":1,
"Ablation":1,
"Database":1,
"Wearable electronic devices":1,
"Killer cells, natural":1,
"Programmed cell death 1":1,
"Biopsy, fine-needle":2,
"Tumor burden":1,
"BRAF, mutation":1,
"Genes, tumor suppressor":1,
"Neurofibromatosis 2":1,
"Proline rich 11 (PRR11)":1,
"S phase arrest":1,
"oncogene":1,
"tongue squamous cell carcinoma (TSCC)":1,
"Diagnostics":1,
"Prophylactic lymph node dissection":1,
"Bulbar symptoms":1,
"Myasthenia gravis":1,
"F-actin":1,
"breast cancer cells":1,
"focal adhesion":1,
"live-cell imaging":1,
"microgravity":1,
"tubulin":1,
"vinculin":1,
"Drug resistance neoplasms":1,
"Targeted therapy":1,
"Heart diseases":1,
"Perioperative care":1,
"adrenal":1,
"circulating miRNA":1,
"endocrine tumors":1,
"BRCA1 mutation":1,
"RET mutation":1,
"cancer genetics":1,
"Beta catenin":1,
"Neoplastic stem cells":1,
"Sodium-iodine symporter":1,
"thyroglobulin":1,
"DICER1":1,
"Sertoli–Leydig":1,
"genetic mutation":1,
"multinodular goiter":1,
"sex cord–stromal tumour":1,
"PI3K/AKT pathway":1,
"Vitamin C":1,
"AKR1C2":1,
"Expression":1,
"thyroid digenesis":1,
"autopsy":1,
"metastatic disease":1,
"dermatomyositis":1,
"inflammatory myopathy":1,
"polymyositis":1,
"thyroid gland papillary cancer":1,
"VASN":1,
"YAP/TAZ":1,
"epithelial-mesenchymal transition (EMT)":1,
"CASTLE":1,
"Chemoradiotherapy":1,
"Debulking surgery":1,
"cystic metastasis":1,
"neck neoplasms":1,
"patient and surgeon candidacy":1,
"vestibular approach":1,
"Case report":1,
"Cervix":1,
"Lung adenocarcinoma":1,
"Ovary":1,
"Cribriform-morular":1,
"familial adenomatous polyposis":1,
"Atypical cytology":1,
"Molecular tests":1,
"Noninvasive follicular thyroid neoplasms with papillary-like nuclear features":1,
"PMRT":1,
"local recurrence":1,
"KLF11":1,
"NR4A3":1,
"hyperthermia":1,
"Adenocarcinoma, follicular":1,
"DJ-1":1,
"phosphatase":1,
"tensin homolog":1,
"MALT":1,
"lymphoma":1,
"non-hodgkin":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2019年第2季度论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
